August
29
Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products
August
29
Chr. Hansen gears up for a sustainable future
August
28
As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness